000 01559 a2200433 4500
005 20250512194543.0
264 0 _c19841101
008 198411s 0 0 eng d
022 _a0022-5282
024 7 _a10.1097/00005373-198409001-00008
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLewis, R A
245 0 0 _aHow are prostaglandins and leukotrienes involved in immunological alterations?
_h[electronic resource]
260 _bThe Journal of trauma
_cSep 1984
300 _aS125-37 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aArachidonic Acids
_ximmunology
650 0 4 _aAspirin
_xtherapeutic use
650 0 4 _aBurns
_xdrug therapy
650 0 4 _aCell Membrane Permeability
650 0 4 _aDinoprostone
650 0 4 _aEosinophils
_ximmunology
650 0 4 _aFree Radicals
650 0 4 _aHumans
650 0 4 _aInflammation
_ximmunology
650 0 4 _aLeukotriene B4
_ximmunology
650 0 4 _aNeutrophils
_ximmunology
650 0 4 _aProstaglandins
_ximmunology
650 0 4 _aProstaglandins E
_ximmunology
650 0 4 _aReceptors, Immunologic
_ximmunology
650 0 4 _aReceptors, Leukotriene B4
650 0 4 _aSRS-A
_ximmunology
650 0 4 _aSkin
_xblood supply
650 0 4 _aSteroids
_xtherapeutic use
650 0 4 _aThromboxane-A Synthase
_xantagonists & inhibitors
773 0 _tThe Journal of trauma
_gvol. 24
_gno. 9 Suppl
_gp. S125-37
856 4 0 _uhttps://doi.org/10.1097/00005373-198409001-00008
_zAvailable from publisher's website
999 _c6090789
_d6090789